Clinical Trial: A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329972) titled 'A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants' on Nov. 20, 2025.

Brief Summary: This study is a phase 1, open-label, randomized, four-period crossover study to evaluate the effect of food and rabeprazole on the ZN-A-1041 tablet formulation in healthy male and female participants.

Study Start Date: Nov. 21, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ZN-A-1041 Formulation 1

Participants will receive a single dose of ZN-A-1041 Formulation 1 on each specified treatment.

DRUG: ZN-A-1041 Formulation 2

Participant...